Ectopic expression of the serotonin 1c receptor and the triggering of malignant transformation.
about
Human colorectal cancers express a constitutively active cholecystokinin-B/gastrin receptor that stimulates cell growthEpstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptorsMuscarinic acetylcholine receptor subtypes as agonist-dependent oncogenesVentricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortexActivation of 5-HT1A receptors expressed in NIH-3T3 cells induces focus formation and potentiates EGF effect on DNA synthesisG-protein-coupled receptor genes as protooncogenes: constitutively activating mutation of the alpha 1B-adrenergic receptor enhances mitogenesis and tumorigenicityThe alpha 1C-adrenoceptor in human prostate: cloning, functional expression, and localization to specific prostatic cell typesProtease-Activated Receptors and other G-Protein-Coupled Receptors: the Melanoma ConnectionExosomes: The Link between GPCR Activation and Metastatic Potential?Genetic polymorphisms of CASR and cancer risk: evidence from meta-analysis and HuGE reviewRole and therapeutic potential of G-protein coupled receptors in breast cancer progression and metastasesThe membrane IgM-associated proteins MB-1 and Ig-beta are sufficient to promote surface expression of a partially functional B-cell antigen receptor in a nonlymphoid cell lineG protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivoProduction and characterization of monoclonal antibodies sensitive to conformation in the 5HT2c serotonin receptor.Metabotropic glutamate receptor 1 (Grm1) is an oncogene in epithelial cells.Expression of serotonin receptor 2c in rat type II pneumocytes.G2A is an oncogenic G protein-coupled receptor.The thrombin receptor, PAR-1, causes transformation by activation of Rho-mediated signaling pathways.The peripheral cannabinoid receptor, Cb2, in retrovirally-induced leukemic transformation and normal hematopoiesis.Neuroendocrine differentiation in prostatic carcinoma.Muscarinic acetylcholine receptor down-regulation limits the extent of inhibition of cell cycle progression in Chinese hamster ovary cells.Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenografts.The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer.Evaluation of neuroendocrine markers in renal cell carcinomaAbnormalities in G protein-coupled signal transduction pathways in human disease.Identification of a prostate-specific G-protein coupled receptor in prostate cancer.Calpain as an effector of the Gq signaling pathway for inhibition of Wnt/beta -catenin-regulated cell proliferationRho GTPase-dependent transformation by G protein-coupled receptors.Virally encoded 7TM receptors.The 5HT2 receptor defines a family of structurally distinct but functionally conserved serotonin receptors.Regulation of mitogen-activated protein kinase signaling networks by G protein-coupled receptors.Regions of the alpha 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological functionInhibitors of glutamate release from breast cancer cells; new targets for cancer-induced bone-pain.Suppression of G-protein-coupled receptor kinase 3 expression is a feature of classical GBM that is required for maximal growth.Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma.Mitogenic pathways regulated by G protein oncogenes.Mining the receptorome.Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cellsTumor-suppressor function of muscarinic acetylcholine receptors is associated with activation of receptor-operated calcium influx.Regulation of E-cadherin-mediated adhesion by muscarinic acetylcholine receptors in small cell lung carcinoma.
P2860
Q22254675-C120F114-CA7A-43ED-93A6-D4388553858EQ24314660-78E61005-4C6C-451D-9BB8-181FD375EA8DQ24321117-95CB151A-7D7B-4ABB-82DD-0109E973FA65Q24321349-CB21BF9E-8FD8-4B73-A942-4E0BD2F6AAB6Q24337397-42B5C665-3387-4006-A817-648DFD66C8F2Q24559956-8197F883-0DD1-49E6-ABCF-41603D0C6C70Q24679775-314038D2-4906-4F7C-9D66-AC82AAF463C9Q26744512-01794D40-909E-434A-A6D8-D466084ADE31Q26752479-5055887C-93BD-4DEC-A7FE-AF0EB1E4640BQ26765295-14C57F3C-E0A7-4836-8610-7623DC610D41Q28084420-25DA0A1E-34EA-48A8-8096-861BDD39252CQ28507085-06DFD224-1DAF-4C23-AA5D-EFF26C7FF627Q28512542-9F799B52-F5EF-4BCA-B750-BCF6D7ACE832Q30360451-78A973D7-C2A0-47ED-A57A-496A83448EA2Q30570451-D14A72BD-0FFA-4F93-A807-5C1600094554Q30701001-0A0BBCBC-E1ED-433A-AC8F-83304F84EA40Q30908412-A4DD4111-0C41-4B32-B104-B20721304C96Q30989694-60D54941-98B4-4559-8AD4-500D71B7251EQ33536282-FA4DC7DF-401C-42A4-91E4-24B87EEDE791Q33604393-690FD45B-36C0-4C18-8888-93616BD5A4CCQ33743930-5AE97672-5FF0-4826-8BF0-CD39C49FAF34Q33762032-2CC923DD-4124-439C-AF52-66D677E23324Q33799070-8B4A7EFF-66E4-440B-8615-2A2C1ACCB2B5Q33875362-4AC2EA97-C813-42FA-B731-2236D242945FQ33900844-09D3F218-396C-4EE6-9868-ED05714D1468Q34094393-08652963-0CC1-4FB6-A643-EEA0A6F2F8F0Q34192418-EAEAED6A-C4F6-40BB-91CE-6961D5D7181BQ34225958-A5BA2994-95ED-4F85-B96B-214057AC8B65Q34225991-BE555E85-3E21-4A43-ADAA-D8508BA791C4Q34419983-09A5E3B5-16C7-4C0B-88E4-A02564FF9252Q34467657-2FED880B-3EDE-459B-BA61-1351AEADF8BEQ34629220-4ABBFB7B-C0E1-462D-9083-DA0E6BB8305EQ35070083-CC46E4D2-4485-40D3-8A43-8E47F8F5872AQ35683150-5B120DA9-4F29-4DF7-AF3E-7185542B169FQ35872949-634989F6-4A6E-4E56-BDC4-7F7F8F9FBDF1Q35930300-64C871C0-EFC1-475C-9A8E-C3E24FDA34E0Q35980130-8CE98F70-1940-432D-9512-0B3665D5CB6BQ36021048-4DCCB247-001C-4821-BF92-B23E2459E751Q36125732-F084E82B-6583-4C45-955C-1C55C64EEFE2Q36232446-612C587D-0C31-49B8-AFA9-E38B816B03B7
P2860
Ectopic expression of the serotonin 1c receptor and the triggering of malignant transformation.
description
1989 nî lūn-bûn
@nan
1989 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Ectopic expression of the sero ...... g of malignant transformation.
@ast
Ectopic expression of the sero ...... g of malignant transformation.
@en
Ectopic expression of the sero ...... g of malignant transformation.
@nl
type
label
Ectopic expression of the sero ...... g of malignant transformation.
@ast
Ectopic expression of the sero ...... g of malignant transformation.
@en
Ectopic expression of the sero ...... g of malignant transformation.
@nl
prefLabel
Ectopic expression of the sero ...... g of malignant transformation.
@ast
Ectopic expression of the sero ...... g of malignant transformation.
@en
Ectopic expression of the sero ...... g of malignant transformation.
@nl
P356
P1433
P1476
Ectopic expression of the sero ...... g of malignant transformation.
@en
P2093
P304
P356
10.1126/SCIENCE.2727693
P407
P577
1989-06-01T00:00:00Z